SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:148087125"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:148087125" > An App knock-in rat...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Pang, KL (author)

An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2021-11-17
  • Springer Science and Business Media LLC,2022

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:148087125
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:148087125URI
  • https://doi.org/10.1038/s41422-021-00582-xDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • A major obstacle in Alzheimer’s disease (AD) research is the lack of predictive and translatable animal models that reflect disease progression and drug efficacy. Transgenic mice overexpressing amyloid precursor protein (App) gene manifest non-physiological and ectopic expression of APP and its fragments in the brain, which is not observed in AD patients. The App knock-in mice circumvented some of these problems, but they do not exhibit tau pathology and neuronal death. We have generated a rat model, with three familiar App mutations and humanized Aβ sequence knocked into the rat App gene. Without altering the levels of full-length APP and other APP fragments, this model exhibits pathologies and disease progression resembling those in human patients: deposit of Aβ plaques in relevant brain regions, microglia activation and gliosis, progressive synaptic degeneration and AD-relevant cognitive deficits. Interestingly, we have observed tau pathology, neuronal apoptosis and necroptosis and brain atrophy, phenotypes rarely seen in other APP models. This App knock-in rat model may serve as a useful tool for AD research, identifying new drug targets and biomarkers, and testing therapeutics.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Jiang, RC (author)
  • Zhang, W (author)
  • Yang, ZY (author)
  • Li, LL (author)
  • Shimozawa, MKarolinska Institutet (author)
  • Tambaro, SKarolinska Institutet (author)
  • Mayer, JKarolinska Institutet (author)
  • Zhang, BG (author)
  • Li, M (author)
  • Wang, JS (author)
  • Liu, H (author)
  • Yang, AL (author)
  • Chen, X (author)
  • Liu, JZ (author)
  • Winblad, BKarolinska Institutet (author)
  • Han, H (author)
  • Jiang, TZ (author)
  • Wang, WW (author)
  • Nilsson, PKarolinska Institutet (author)
  • Guo, W (author)
  • Lu, B (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:Cell research: Springer Science and Business Media LLC32:2, s. 157-1751748-78381001-0602

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view